Anti-Infective Polypeptides for Combating Bacterial and Viral Infections

  1. Mathias Hornef
  2. Klaus Brandenburg
  3. Ulrike Protzer
  4. Krepstakies Krepstakies
  5. Thomas Gutsmann
  6. Julie Lucifora
  7. Beate Schittl
  8. Patrick Garidel
  9. Joachim Hauber
  10. Aline Dupont
  11. Lena Heinbockel
  12. Sabine Dömming
  13. Tobias Schürholz
  14. Volker Moennig
  15. Stefanie Schmeiser
  16. Wolfram Brune
  17. Eva Krause
  18. Yani Kaconis
  19. Susana Sánchez-Gómez
  20. Guillermo M. de Tejada
Libro:
Frontiers in Clinical Drug Research: Anti-Infectives

Editorial: Bentham Science Publishers

ISBN: 978-1-60805-854-9 978-1-60805-855-6

Año de publicación: 2014

Páginas: 3-31

Tipo: Capítulo de Libro

DOI: 10.2174/9781608058549114010003 GOOGLE SCHOLAR lock_openAcceso abierto editor

Resumen

Bacterial and viral infections are still a major threat of human health. The increasing resistance of bacterial isolates to common antibiotics and the lack of new compounds reaching the clinic leading to serious problems in health care. The variability of different virus families with individual entry pathways and replication strategies make the development of suitable therapeutics with cross-species activity complicated. Furthermore, the infections often cause each other, so that an initial virus infection is frequently accompanied by a bacterial "superinfection" with severe consequences.We developed a new class of compounds based on polypeptides, which exhibit broadspectrum antiviral activity with simultaneous inhibition of important bacterial pathogenicity factors such as lipopolysaccharide (LPS, endotoxin) and lipoproteins. Here, we summarise recent results and discuss them in the context of the progress made in the field of polypeptides as novel anti-infective therapeutic agents.